Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Intensive care medicine, Neutrophilia, and Foundation (evidence).
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
Phage Therapy of <i>Mycobacterium</i> Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammation
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
CFTR modulator theratyping: Current status, gaps and future directions
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations
Diagnosis of Cystic Fibrosis in Nonscreened Populations
Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease
The Role of Leptin in the Development of Pulmonary Neutrophilia in Infection and Acute Lung Injury*